University of Wisconsin
Otolaryngology residency · Madison, WI · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of Wisconsin–Madison's research in otolaryngology, which the program shares with other departments and affiliated hospitals.
About University of Wisconsin–Madisoninstitution-wide otolaryngology research
Otolaryngology publications from University of Wisconsin–Madison and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
15
works per year
19th of 56 otolaryngology residency programs
-9.4%
2-year growth
37th of 54 otolaryngology residency programs
17.8%
in top 10% of field (works before 2025)
32nd of 39 otolaryngology residency programs
46.7%
cited above world average
29th of 39 otolaryngology residency programs
Works per year · * 2026 so far
Otorhinolaryngology · 75
Otolaryngology research topics at University of Wisconsin–Madison
Papers in the window; each links to the list on OpenAlex.
Most cited at University of Wisconsin–Madison since 2024
All otolaryngology papers there on OpenAlex
- NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025Alexander Dimitrios Colevas et al. · Journal of the National Comprehensive Cancer Network · 2025 · PubMed · cited 228
- Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice GuidelineDanielle Nina Margalit et al. · Practical Radiation Oncology · 2024 · PubMed · cited 57
- Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck CancerPaul Loren Swiecicki et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 32
- Allergic Fungal Rhinosinusitis Diagnosis, Management, Associated Conditions, Pathophysiology, and Future Directions: Summary of a Multidisciplinary WorkshopLauren T. Roland et al. · International Forum of Allergy & Rhinology · 2025 · PubMed · cited 12
- Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysisLaila A. Gharzai et al. · The Lancet Oncology · 2024 · PubMed · cited 10
- CDKN2A deletion in p16‐negative/ HPV ‐positive head and neck squamous cell carcinoma: Highlighting the molecular basis behind the limitation of relying on p16 immunohistochemistry as a surrogate marker for HPV involvementTrevor Teich et al. · Histopathology · 2025 · PubMed · cited 6
- From Bench to Bedside: A Team’s Approach to Multidisciplinary Strategies to Combat Therapeutic Resistance in Head and Neck Squamous Cell CarcinomaBridget E. Crossman et al. · Journal of Clinical Medicine · 2024 · PubMed · cited 6
- MK2 promotes p16 negative head and neck cancer migration, invasion, and metastasisDeri Morgan et al. · Cancer Letters · 2025 · PubMed · cited 5
- Uncommon and Challenging Phenotypes of High-Risk Human Papillomavirus-Associated Head and Neck Carcinomas Revealed by High-Throughput StudiesAlex P. Tannenbaum et al. · Head and Neck Pathology · 2024 · PubMed · cited 4
- Mutational signature-based classification uncovers emerging oral cancer subtypes with distinct molecular patternsSophie Deneuve et al. · International Journal of Oral Science · 2026 · PubMed · cited 3